MyndTec (XCNQ:MYTC) Treasury Stock : C$0.00 Mil (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is MyndTec Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. MyndTec's treasury stock for the quarter that ended in Sep. 2024 was C$0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

MyndTec Treasury Stock Historical Data

The historical data trend for MyndTec's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MyndTec Treasury Stock Chart

MyndTec Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Treasury Stock

MyndTec Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Treasury Stock	Get a 7-Day Free Trial											-	-	-	-	-

MyndTec Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

MyndTec Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MyndTec Inc (XCNQ:MYTC) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

1900 Minnesota Court, Suite 122, Mississauga, ON, CAN, L5N 3C9

Website

https://www.myndtec.com

MyndTec Inc is a medical technology company. It researches, develops, and distributes new therapies designed to improve function, maximize independence and enhance the quality of life for individuals with upper limb paralysis due to stroke, spinal cord injury, or traumatic brain injury. The firm develops non-invasive neurological and nervous system electrical stimulation therapeutics for the treatment of neurological diseases and injuries specifically targeted to markets with large, growing, and patient populations. The company generates revenues from sales in Canada and the United States.

MyndTec Headlines

No Headlines